Website & contact details
- Group website
- The site of this company’s group or brand.
GSK Finance (No 2) Limited
- Incorporated
- 12 December 2018 (7 years)
- Industry
- Other service activities n.e.c. (96090)
- Owned by
- Accounts type
- Full
- Region
- Greater London
- Address
- 79 New Oxford StreetLondonWC1A 1DG
Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 5 October 2027
- Last conf. stmt
- 21 September 2026
Officers 6 active
Officer details are public data from the Companies House register.
Director · Appointed 2 March 2026
British
Born January 1979 (47)
Director · Appointed 1 May 2023
British
Born March 1962 (64)
Whyte, Victoria Anne
Secretary · Appointed 12 December 2018
Director · Appointed 12 December 2018
British
Born November 1967
Corporate Director · Appointed 12 December 2018
Corporate Director · Appointed 12 December 2018
Officer history (2 former)
2 March 2026
1 May 2023
1 May 2023
1 May 2019
1 May 2019
12 December 2018
Appointed Whyte, Victoria Anne as Secretary
12 December 2018
12 December 2018
12 December 2018
12 December 2018
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 12 December 2018
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Public Limited Company
Reg. no. 00242686
Holdings 3
Companies where GSK Finance (No 2) Limited is registered as a person with significant control
Owns 75–100% of shares
In liquidation
Owns 25–50% of shares
Active
Owns 75–100% of shares
Active
Group structure 22 shown
Ownership group derived from the Companies House PSC register
British Pharma Group Limited Holds 25–50% of voting rights
Glaxosmithkline Holdings (One) Limited Owns 75–100% of shares
Glaxosmithkline Holdings Limited Owns 75–100% of shares
Glaxosmithkline Finance PLC Owns 75–100% of shares
Glaxo Group Limited Owns 75–100% of shares
Glaxosmithkline Ihc Limited Owns 75–100% of shares
GSK Finance (No 2) Limited This company Owns 75–100% of shares
Setfirst Limited Owns 75–100% of shares
Smithkline Beecham Limited Owns 75–100% of shares
Wellcome Limited Owns 75–100% of shares
Glaxosmithkline Mercury Limited Owns 75–100% of shares
Viiv Healthcare Limited Owns 75–100% of shares
Viiv Healthcare Finance 2 Limited Owns 75–100% of shares
Viiv Healthcare Overseas Limited Owns 75–100% of shares
Viiv Healthcare Trading Services UK Limited Owns 75–100% of shares
Viiv Healthcare UK (No.4) Limited Owns 75–100% of shares
Viiv Healthcare UK (No.5) Limited Owns 75–100% of shares
Viiv Healthcare UK (No.6) Limited Owns 75–100% of shares
Viiv Healthcare UK (No.7) Limited Owns 75–100% of shares
Viiv Healthcare UK Limited Owns 75–100% of shares
Glaxosmithkline Services Unlimited Owns 75–100% of shares
Filings 49
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 21 September 2026 | Confirmation statement with updates | 21 September 2026 | ||
| 8 September 2026 | Statement of capital following an allotment of shares | |||
| 14 July 2026 | Full accounts | 31 December 2025 | ||
| 8 May 2026 | Statement of capital following an allotment of shares | |||
| 3 March 2026 | Appointment of a director |
Some other companies at this address
Other companies in this industry
Totnes
Salford
London
Watford
London
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →